Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
SynopsisP

Mass sociogenic illness

Erica Weir
CMAJ January 04, 2005 172 (1) 36; DOI: https://doi.org/10.1503/cmaj.045027
Erica Weir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
  • © 2005 Canadian Medical Association or its licensors

Background and epidemiology: Mass sociogenic illness refers to the “rapid spread of illness signs and symptoms affecting members of a cohesive group, originating from a nervous system disturbance involving excitation, loss or alteration of function, whereby physical complaints that are exhibited unconsciously have no corresponding organic aetiology.”1 It occurs in the context of a credible threat that provokes great anxiety, such as a noxious odour in a school amid fears of chemical warfare or bioterrorism. In standard psychiatric nomenclature, mass sociogenic illness is subsumed under the general heading of somatoform disorder and subcategorized as “conversion disorder hysterical neurosis, conversion type.” In the literature, it is synonymously termed mass psychogenic disorder or epidemic hysteria and distinguished from collective delusions by the presence of illness symptoms.2

Most physicians, through experience or training in psychiatry, are aware of individual cases of “hysteria” or somatoform disorders. They are less educated and knowledgeable about epidemic hysteria, even though a review of the literature reveals over 200 published accounts of mass responses to situations involving suspected poisonings and other events.3One example in September 1998 involved 800 children in Jordan who believed they had suffered from the side effects of tetanus–diphtheria toxoid vaccine administered at school; 122 of the children were admitted to hospital. For the vast majority, symptoms resulted not from the vaccine but from psychogenic illness.3

The impact of such events is underappreciated and underreported. They place significant financial burdens on emergency services, public health and environmental agencies and the affected building or occupation site, which is often closed for days or weeks.

Part of the difficulty in recognizing outbreaks of mass sociogenic illness has to do with its diverse nature.1 A historical review of these events suggests that the features of mass sociogenic illnesses tend to mirror popular social and cultural preoccupations that define distinct eras and reflect unique social beliefs about the nature of the world. Before the 20th century most reports of mass sociogenic illness involved motor hysteria incubated by exposure to long-standing religious, academic or workplace discipline.1 These produced outbreaks of convulsions, contractures, tremors, paralysis and laughing. In the 20th century and on to the present, strange odours presumed to be an environmental contaminant or toxic gas from a bioterrorist or chemical warfare attack have been commonly blamed in episodes of mass hysteria, producing breathlessness, nausea, headache, dizziness and weakness in affected people. For instance, during the 1990 Gulf War the first missile attack on Israel by Iraq was widely feared to contain chemical weapons. Although such fears were unfounded, about 40% of civilians in the immediate vicinity of the attack reported breathing problems.1

Clinical management: The confluence of 8 symptoms or conditions typically indicates mass sociogenic illness and permits a presumptive diagnosis while investigations are underway. These include symptoms with no plausible organic basis; symptoms that are transient and benign; symptoms with rapid onset and recovery; occurrence in a segregated group; the presence of extraordinary anxiety; symptoms that are spread via sight, sound or oral communication; a spread that moves down the age scale, beginning with older or higher-status people; and a preponderance of female participants.1

When faced with the prospect of an outbreak of mass sociogenic illness, physicians should involve public health officials in the investigation. A prompt diagnosis is problematic because controversy often surrounds outbreaks and time is needed to analyze environmental and medical test results. It is often advisable to close the building or area until negative results are returned. This action serves to control the outbreak by reducing anxiety levels and temporarily dispersing the group.1,4

Treatment involves identifying and reducing or eliminating the stress-related stimulus.4

Prevention: No one or group is immune from mass sociogenic illness. Attempts to identify predisposing factors and susceptibilities have produced conflicting results.1 Understanding the historical shifts in the manifestations of these outbreaks, the fears and uncertainties that preoccupy current cultures and the distinctive features of mass sociogenic illness that appear to transcend historical context will assist in more rapid recognition and treatment of outbreaks.

References

  1. 1.↵
    Bartholomew R, Wessley S. Protean nature of mass sociogenic illness: from possessed nuns to chemical and biological terrorism fears. Br J Psychiatry 2002;180:300-6.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Bartholomew RE. Epidemic hysteria: a review of the published literature [letter]. Am J Epidemiol 2000;151: 206-7.
    OpenUrlFREE Full Text
  3. 3.↵
    KharabshehS, Al-Otoum H, Clements J, Abbas A, Khuri-Bulos N, Belbesi A, et al. Mass psychogenic illness following tetanus–diphtheria toxoid vaccination in Jordan. Bull World Health Organ 2001;79(8):764-70.
    OpenUrlPubMed
  4. 4.↵
    Jones TF. Mass psychogenic illness: role of the individual physician. Am Fam Physician 2000;62:2649-53,2655-6.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 172 (1)
CMAJ
Vol. 172, Issue 1
4 Jan 2005
  • Table of Contents
  • Index by author
  • Canadian Adverse Reaction Newsletter (127-138)

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mass sociogenic illness
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Mass sociogenic illness
Erica Weir
CMAJ Jan 2005, 172 (1) 36; DOI: 10.1503/cmaj.045027

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Mass sociogenic illness
Erica Weir
CMAJ Jan 2005, 172 (1) 36; DOI: 10.1503/cmaj.045027
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science
  • Google Scholar

More in this TOC Section

  • The changing ecology of avian flu
  • Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension
  • A newborn requiring selective bronchial intubation
Show more Synopsis

Similar Articles

Collections

  • Topics
    • Public health

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire